Niagen Bioscience Inc Financial Ratios — NAGE Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-123.58	-152.41	-49.05	-52.56	-18.31	-15.21	-27.59	-63.49	-77.95	-50.7	-56.4	-29.56	-9.06	13.88	19.9
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.67	-10.2
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.58	21.37
Gross Margin (%)	30.47	19.6	30.84	34.78	42.13	47.96	49.42	50.88	55.67	59.53	61.51	59.4	60.76	61.84	64.28
EBITDA Margin (%)	-92.02	-97.26	-40.07	-32.18	-9.7	-11.47	-73.87	-102.45	-64.33	-30.95	-37.73	-23.24	-4.66	9.25	12.17
Operating Margin (%)	-96.94	-100.22	-42.73	-33.86	-11.55	-13.41	-77.25	-105.12	-67.62	-33.5	-40.14	-25.85	-6.7	7.76	11.05
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	83.14	22.03
Pretax Margin (%)	-97.32	-100.45	-43.5	-35.19	-14.72	-16.39	-77.97	-105.57	-69.45	-33.62	-40.22	-22.96	-5.91	8.89	14.06
Profit Margin (%)	-97.32	-100.45	-43.5	-35.19	-15.49	-13.52	-53.67	-105.57	-69.45	-33.62	-40.22	-22.96	-5.91	8.58	13.43
Net Income to Common Margin (%)	-97.32	-100.45	-43.5	-35.19	-15.49	-13.52	-53.67	-105.57	-69.45	-33.62	-40.22	-22.96	-5.91	8.58	13.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.44	4.45
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	3	6	1	1	- -	2	2	5	4	3	3	3
ST Debt	- -	- -	- -	- -	2	- -	- -	- -	1	1	1	1	1	1	1
LT Debt	- -	- -	- -	2	4	- -	- -	- -	1	1	4	4	3	2	2
Total Debt/EBITDA	-0.03	-0.02	-0.1	-0.56	-3.19	-0.24	-0.03	-0.01	-0.06	-0.09	-0.18	-0.25	-0.84	0.29	0.18
Net Debt/EBITDA	0.06	0.05	0.56	0.36	0.39	0.66	2.9	0.69	0.63	0.9	1.1	1.21	6.98	-4.83	-4.1
Total Debt/EBIT	-0.03	-0.02	-0.1	-0.53	-2.68	-0.21	-0.03	-0.01	-0.05	-0.08	-0.17	-0.23	-0.59	0.34	0.2
Net Debt/EBIT	0.05	0.04	0.52	0.34	0.33	0.57	2.77	0.68	0.59	0.83	1.03	1.09	4.85	-5.76	-4.52
EBITDA to Interest Expense	-232.26	-389.31	-118.61	-31.02	-2.82	-6.68	- -	- -	-35.16	-258.32	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-237.76	-391.95	-125.2	-32.6	-3.87	-11.32	- -	- -	-36.04	-260.32	- -	- -	- -	- -	- -
EBIT to Interest Expense	-244.67	-401.17	-126.46	-32.64	-3.35	-7.81	- -	- -	-36.95	-279.63	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	1	- -	- -	- -	1	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-286.79	-327.9	-378.68	-342.27	-225.39	-228.77	-90.15	-212.39	-302.73	-369.58	-291.99	-343.01	-346.38	-266.31	-154.55
Long-Term Debt/Equity (%)	6.43	3.72	4.95	60.03	71.85	3.44	0.58	0.5	4.24	6.19	13.09	12.42	9.05	3.59	2.37
Long-Term Debt/Capital (%)	-0.93	-0.5	-0.83	-6.55	-10.32	-0.77	-0.55	-0.15	-0.72	-0.73	-2.53	-1.97	-1.38	-0.92	-1.12
Long-Term Debt/Total Assets (%)	2.63	1.64	3.12	20.84	20.21	1.74	0.49	0.32	2.15	2.65	7.18	6.59	4.68	2.43	1.71
Total Debt/Equity (%)	9.45	5.65	7.4	69.32	105	6.01	0.94	1.14	8.41	9.97	14.82	14.85	11.52	5.75	3.68
Total Debt/Capital (%)	-1.36	-0.77	-1.25	-7.56	-15.08	-1.34	-0.9	-0.35	-1.43	-1.17	-2.86	-2.35	-1.75	-1.48	-1.74
Total Debt/Total Assets (%)	3.86	2.5	4.66	24.07	29.54	3.03	0.81	0.73	4.27	4.27	8.13	7.88	5.96	3.88	2.65
Net Debt to Equity	-16.4	-13.02	-39.91	-44.12	-12.81	-16.47	-84.31	-82.48	-91.03	-100.44	-88.31	-70.76	-95.49	-96.56	-84.46
Net Debt/Capital (%)	2.31	1.74	6.3	4.34	1.6	3.55	44.75	20.05	13.42	10.53	14.58	10.07	12.68	19.9	28.57
EBITDA	-7	-11	-4	-5	-2	-2	-16	-32	-30	-18	-25	-17	-4	9	16
EBITDA-CapEx	-8	-11	-4	-5	-2	-4	-17	-34	-31	-18	-26	-17	-4	9	15
Operating Income (Loss)	-8	-12	-4	-5	-2	-3	-16	-33	-31	-20	-27	-19	-6	8	14

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.13	0.11	0.8	0.8	0.58	0.19	5.61	1.55	1.24	1	1.59	1.14	1.32	2.48	3.24
Current Ratio	1.48	1.66	2.04	1.99	1.73	1.77	7.07	2.53	2.23	1.96	2.78	2.61	2.4	3.57	4.86
Quick Ratio	0.34	0.52	1.17	1.18	0.83	0.85	6.27	1.86	1.38	1.16	1.89	1.61	1.57	2.91	3.73
CFO/Avg Current Liab	-1.83	-2.5	-1.03	-0.66	-0.29	-0.32	-1.16	-1.86	-1.39	-0.67	-1.42	-0.85	0.37	0.63	0.71
Common Equity/Total Assets	-286.79	-327.9	-378.68	-342.27	-225.39	-228.77	-90.15	-212.39	-302.73	-369.58	-291.99	-343.01	-346.38	-266.31	-154.55
Long-Term Debt/Equity (%)	6.43	3.72	4.95	60.03	71.85	3.44	0.58	0.5	4.24	6.19	13.09	12.42	9.05	3.59	2.37
Long-Term Debt/Capital (%)	-0.93	-0.5	-0.83	-6.55	-10.32	-0.77	-0.55	-0.15	-0.72	-0.73	-2.53	-1.97	-1.38	-0.92	-1.12
Long-Term Debt/Total Assets (%)	2.63	1.64	3.12	20.84	20.21	1.74	0.49	0.32	2.15	2.65	7.18	6.59	4.68	2.43	1.71
Total Debt/Equity (%)	9.45	5.65	7.4	69.32	105	6.01	0.94	1.14	8.41	9.97	14.82	14.85	11.52	5.75	3.68
Total Debt/Capital (%)	-1.36	-0.77	-1.25	-7.56	-15.08	-1.34	-0.9	-0.35	-1.43	-1.17	-2.86	-2.35	-1.75	-1.48	-1.74
Total Debt/Total Assets (%)	3.86	2.5	4.66	24.07	29.54	3.03	0.81	0.73	4.27	4.27	8.13	7.88	5.96	3.88	2.65
CFO/Total Liabilities	-110.52	-200.74	-117.6	-34.32	-15.67	-30.03	-110.28	-138.89	-103.22	-48.33	-92.53	-59.48	26.85	54.58	45.2
CFO/CapEx	-23.2	-132.17	-17.26	-10.25	-3.26	-1.7	-7.26	-14.4	-27.14	-74.65	-59.08	-45.2	48.09	74.29	46.25
Altman's Z-Score	-0.6	-1.57	21.94	2.91	3.68	5.34	16.83	3.17	2.17	3.03	1.9	-1.25	-0.64	9.81	10.5

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	9.4	8.72	7.31	11.16	8.21	5.22	3.79	6.51	14.17	24.34	17.03	10.51	12.19	15.32	14.78
Days Sales Outstanding	38.81	41.88	49.92	32.72	44.46	69.94	96.32	56.08	25.76	15	21.43	34.72	29.95	23.82	24.69
Inventory Turnover	2.61	2.3	1.9	3.36	1.74	1.4	1.56	2.21	2.07	2.07	2.05	2.07	2.25	3.21	3.12
Days Inventory Outstanding	140.05	158.57	192.41	108.51	209.97	260.4	233.29	165.35	175.94	176.68	177.75	176.42	162.53	113.87	116.9
Accounts Payable Turnover	5.15	4.1	1.65	4.71	3.06	1.81	1.78	2.71	2.48	2.53	2.81	3.02	3.28	3.48	5.95
Accounts Payable Turnover Days	70.84	89.07	220.68	77.52	119.39	202.21	205.61	134.85	146.98	144.23	130.07	120.96	111.34	104.76	61.36
Cash Conversion Cycle	108.02	111.37	21.64	63.71	135.04	128.13	124.01	86.58	54.72	47.44	69.12	90.18	81.15	32.94	80.23
Inventory to Cash Days	-101.24	-116.69	-142.49	-75.79	-165.51	-190.46	-136.97	-109.27	-150.18	-161.68	-156.33	-141.7	-132.58	-90.05	-92.21
Inventories	3	5	2	4	8	8	6	8	12	12	14	15	15	9	20
Raw Materials	1	1	1	2	7	7	4	2	1	3	2	3	4	1	7
Work In Process	- -	- -	- -	- -	- -	- -	- -	3	5	6	4	3	4	2	3
Finished Goods	1	3	- -	- -	- -	- -	1	2	5	2	7	8	6	6	10
Other Inventory	2	2	2	2	1	1	1	1	1	1	1	- -	1	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	38	48	152	94	131	123	262	189	246	293	251	117	107	403	504
- Cash & Cash Equivalents	- -	1	2	4	6	2	45	22	19	16	28	20	27	45	65
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	3	6	1	1	- -	2	2	5	4	3	3	3
Enterprise Value	37	48	150	92	131	122	217	167	229	278	228	101	83	361	442
Total Capital	-18	-29	-34	-37	-37	-45	-56	-89	-120	-140	-164	-181	-187	-179	-162
Total Debt/Capital (%)	-1.36	-0.77	-1.25	-7.56	-15.08	-1.34	-0.9	-0.35	-1.43	-1.17	-2.86	-2.35	-1.75	-1.48	-1.74
Total Debt / EV	0.01	- -	- -	0.03	0.04	- -	- -	- -	0.01	0.01	0.02	0.04	0.04	0.01	0.01
EV/Sales	4.61	4.1	14.78	6.04	7.34	5.65	10.25	5.28	4.95	4.7	3.38	1.4	1	3.63	3.41
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	39.23	28.05
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.77	30.9
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.71	29.84	32.71
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.47	29.44	32.02
Diluted Market Cap	38	51	152	94	131	123	262	189	246	293	251	117	107	415	543
Diluted Enterprise Value	37	51	150	92	131	122	217	167	229	278	228	101	83	373	482
EV per Share	1.64	1.58	4.5	2.61	3.66	3.28	4.87	3.03	4.01	4.56	3.39	1.45	1.11	4.76	5.58
TTM Sales	8	12	10	15	18	22	21	32	46	59	67	72	84	100	129
TTM EBITDA	-7	-11	-4	-5	-2	-2	-16	-32	-30	-18	-25	-17	-4	9	16
TTM Operating Income	-8	-12	-4	-5	-2	-3	-16	-33	-31	-20	-27	-19	-6	8	14
TTM Cash Flow to Firm	-4	-10	-4	-2	-1	-3	-10	-21	-20	-11	-24	-15	7	12	14
TTM Free Cash Flow to Firm	-4	-10	-4	-2	-1	-1	-8	-19	-19	-10	-24	-15	7	12	14

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-9.58	-5.07	-41.3	-40.23	-89.73	-101.88	-31.02	-9.7	-12.49	-28.03	-10.58	-7.93	14.76	33.8	39.39
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.77	30.9
Enterprise Value	37	48	150	92	131	122	217	167	229	278	228	101	83	361	442
Low Price	1.44	1.32	1.5	2.4	2.52	2.25	2.26	2.79	2.68	2.5	3.7	1.15	1.25	1.36	5.16
EV/Sales	4.61	4.1	14.78	6.04	7.34	5.65	10.25	5.28	4.95	4.7	3.38	1.4	1	3.63	3.41
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	39.23	28.05
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	47.16	28.97
Price/Earnings Average	-11.35	-5.48	-18.61	-27.2	-48.16	-48.1	-14.77	-6.92	-6.97	-13.82	-18.73	-8.29	-23.63	30.85	37.91
Price/Earnings High	-17.56	-9.68	-37.33	-42.48	-66.81	-78.71	-28.38	-10.95	-8.79	-18.39	-58.6	-16.99	-34.02	70.78	66.92
Price/Earnings Low	-4.15	-3.41	-11.31	-15.81	-32.63	-28.66	-8.86	-4.61	-4.76	-7.66	-9.16	-4.85	-18.98	12.08	23.5
Price/Book Value	-2.09	-1.61	-4.47	-2.38	-3.11	-2.73	-4.64	-2.1	-2.02	-2.07	-1.49	-0.63	-0.56	-2.22	-3.06
Price/Book Value Average	-4.98	-2.16	-2.42	-3.72	-3.16	-3.12	-2.97	-2.57	-1.84	-1.94	-3.01	-0.74	-0.61	-1.45	-4.01
Price/Book Value High	-7.71	-3.81	-4.85	-5.81	-4.38	-5.1	-5.71	-4.07	-2.32	-2.58	-9.41	-1.52	-0.88	-3.33	-7.07
Price/Book Value Low	-1.82	-1.34	-1.47	-2.16	-2.14	-1.86	-1.78	-1.71	-1.26	-1.08	-1.47	-0.43	-0.49	-0.57	-2.48
Price/Tangible Book Value	15.26	12.4	27.82	25.3	26.69	13.01	5.03	7.36	12.85	19.11	8.14	4.18	3.84	8.82	7.11
Price/Tangible Book Value Average	36.42	16.56	15.06	39.58	27.12	14.84	3.22	9	11.7	17.95	16.46	4.9	4.18	5.77	9.3
Price/Tangible Book Value High	56.34	29.25	30.19	61.82	37.62	24.29	6.19	14.23	14.76	23.88	51.49	10.04	6.01	13.23	16.41
Price/Tangible Book Value Low	13.32	10.3	9.15	23	18.37	8.84	1.93	5.99	7.99	9.95	8.05	2.86	3.35	2.26	5.76
Price/Sales	4.63	4.12	14.96	6.12	7.34	5.7	12.37	5.98	5.31	4.95	3.73	1.63	1.28	4.05	3.89
Price/Sales Average	11.05	5.5	8.1	9.57	7.46	6.5	7.93	7.31	4.84	4.65	7.53	1.9	1.4	2.65	5.09
Price/Sales High	17.09	9.72	16.24	14.95	10.35	10.64	15.23	11.56	6.1	6.18	23.57	3.9	2.01	6.08	8.99
Price/Sales Low	4.04	3.42	4.92	5.56	5.06	3.87	4.75	4.86	3.3	2.58	3.69	1.11	1.12	1.04	3.16
Price/Cash Flow	-9.17	-4.73	-38.91	-36.31	-62.2	-42.04	-26.75	-9.02	-12.03	-27.65	-10.4	-7.76	15.07	33.3	37.29
Price/Cash Flow Average	-21.87	-6.31	-21.06	-56.79	-63.21	-47.96	-17.14	-11.03	-10.96	-25.98	-21.03	-9.08	16.4	21.78	48.8
Price/Cash Flow High	-33.83	-11.15	-42.24	-88.7	-87.69	-78.49	-32.94	-17.44	-13.82	-34.57	-65.79	-18.61	23.6	49.98	86.13
Price/Cash Flow Low	-8	-3.92	-12.8	-33.01	-42.83	-28.57	-10.28	-7.34	-7.48	-14.4	-10.29	-5.31	13.17	8.53	30.25
Price/Free Cash Flow Average	-22.85	-6.76	-22.36	-62.93	-91.19	-116.23	-19.88	-11.85	-11.38	-26.33	-21.39	-9.29	16.06	22.12	51.54
Price/Free Cash Flow High	-35.35	-11.95	-44.84	-98.29	-126.5	-190.22	-38.2	-18.74	-14.35	-35.04	-66.92	-19.03	23.12	50.74	90.97
Price/Free Cash Flow Low	-8.36	-4.21	-13.59	-36.57	-61.78	-69.25	-11.92	-7.89	-7.77	-14.6	-10.46	-5.43	12.9	8.66	31.95
EV/Sales Average	11.03	5.48	7.92	9.49	7.46	6.45	5.81	6.61	4.47	4.4	7.19	1.68	1.11	2.23	4.61
EV/Sales High	17.07	9.69	16.06	14.87	10.35	10.59	13.11	10.86	5.74	5.93	23.22	3.68	1.72	5.66	8.51
EV/Sales Low	4.02	3.4	4.74	5.48	5.05	3.83	2.64	4.16	2.94	2.33	3.34	0.89	0.84	0.62	2.68
EV/EBITDA Average	-11.98	-5.63	-19.75	-29.5	-76.88	-56.24	-7.87	-6.45	-6.95	-14.2	-19.05	-7.23	-23.83	24.1	37.92
EV/EBITDA High	-18.55	-9.97	-40.07	-46.21	-106.66	-92.3	-17.75	-10.6	-8.92	-19.17	-61.55	-15.83	-37	61.16	69.94
EV/EBITDA Low	-4.37	-3.49	-11.83	-17.04	-52.09	-33.34	-3.57	-4.06	-4.57	-7.51	-8.85	-3.83	-17.93	6.67	22.02
EV/EBIT Average	-11.37	-5.46	-18.52	-28.03	-64.58	-48.12	-7.52	-6.29	-6.61	-13.12	-17.91	-6.5	-16.58	28.73	41.77
EV/EBIT High	-17.61	-9.67	-37.58	-43.91	-89.6	-78.97	-16.98	-10.33	-8.48	-17.71	-57.85	-14.22	-25.73	72.91	77.04
EV/EBIT Low	-4.15	-3.39	-11.09	-16.19	-43.75	-28.52	-3.41	-3.96	-4.35	-6.94	-8.32	-3.44	-12.47	7.95	24.25
Last Price	1.65	1.59	4.56	2.64	3.66	3.31	5.88	3.43	4.31	4.8	3.74	1.68	1.43	5.31	6.36
High Price	6.09	3.75	4.95	6.45	5.16	6.18	7.24	6.63	4.95	6	23.66	4.03	2.24	7.97	14.69
Enterprise Value Average	89	64	80	145	133	140	123	208	207	260	485	121	93	222	597
Enterprise Value High	138	113	163	228	185	229	278	343	266	352	1,566	265	144	563	1,101
Enterprise Value Low	33	39	48	84	90	83	56	131	136	138	225	64	70	61	347

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	24	31	35	35	36	38	55	55	60	62	68	75	75	77	80
Diluted Weighted Avg Shares	23	32	33	35	36	37	45	55	57	61	67	70	75	78	85
Basic Weighted Avg Shares	23	30	33	35	36	37	45	55	57	61	67	70	75	76	79
Revenue per Share	0.36	0.39	0.3	0.43	0.5	0.58	0.48	0.57	0.81	0.97	1	1.03	1.11	1.31	1.63
EBITDA per Share	-0.33	-0.38	-0.12	-0.14	-0.05	-0.07	-0.35	-0.59	-0.52	-0.3	-0.38	-0.24	-0.05	0.12	0.2
Operating Income per Share	-0.35	-0.39	-0.13	-0.15	-0.06	-0.08	-0.37	-0.6	-0.55	-0.33	-0.4	-0.27	-0.07	0.1	0.18
Basic EPS, GAAP	-0.35	-0.39	-0.13	-0.15	-0.08	-0.08	-0.26	-0.61	-0.56	-0.33	-0.4	-0.24	-0.07	0.11	0.22
Basic EPS from Cont Ops	-0.35	-0.39	-0.13	-0.15	-0.07	-0.1	-0.37	-0.61	-0.56	-0.33	-0.4	-0.24	-0.07	0.11	0.22
Diluted EPS, GAAP	-0.35	-0.36	-0.13	-0.15	-0.08	-0.08	-0.26	-0.61	-0.56	-0.33	-0.4	-0.24	-0.07	0.11	0.2
Diluted EPS from Cont Ops	-0.35	-0.36	-0.13	-0.15	-0.07	-0.1	-0.37	-0.61	-0.56	-0.33	-0.4	-0.24	-0.07	0.11	0.2
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.18	-0.34	-0.12	-0.07	-0.06	-0.08	-0.22	-0.38	-0.36	-0.17	-0.36	-0.22	0.09	0.16	0.17
Free Cash Flow per Basic Share	-0.19	-0.34	-0.12	-0.08	-0.08	-0.12	-0.25	-0.41	-0.37	-0.18	-0.37	-0.22	0.09	0.16	0.17
Cash & Equivalents per Share	0.02	0.02	0.07	0.11	0.15	0.04	1.02	0.41	0.33	0.27	0.42	0.29	0.36	0.59	0.82
Book Value per Share	-0.79	-0.98	-1.02	-1.11	-1.18	-1.21	-1.27	-1.63	-2.14	-2.32	-2.51	-2.66	-2.54	-2.39	-2.08
Tangible Book Value per Share	0.11	0.13	0.16	0.1	0.14	0.25	1.17	0.47	0.34	0.25	0.46	0.4	0.37	0.6	0.9

Niagen Bioscience Inc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)